BCL2 and cancer: Cancer cell inhibition is based on the dose‐dependent manner, and the treatment activated Caspases‐3 and ‐9, which led to the cleavage of poly (ADP‐ribose) polymerase through proteolysis. Additionally, the expression of Bcl‐2 and Bax proteins was decreased and increased